Antifolates are a class of antimetabolite medications that antagonise (that is, block) the actions of folic acid (vitamin B9).[1] Folic acid's primary function in the body is as a cofactor to various methyltransferases involved in serine, methionine, thymidine and purine biosynthesis. Consequently, antifolates inhibit cell division, DNA/RNA synthesis and repair and protein synthesis. Some such as proguanil, pyrimethamine and trimethoprim selectively inhibit folate's actions in microbial organisms such as bacteria, protozoa and fungi. The majority of antifolates work by inhibiting dihydrofolate reductase (DHFR).
Based on the Drugs For Antifolate Compounds market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Drugs For Antifolate Compounds market covered in Chapter 5:
IPCA Laboratories
GlaxoSmithKline
IPCA Laboratories
Mylan Labs
Baoding Zhongbao Chemical
Cipla
Genentech
Bristol-Myers
Eli Lilly
Alimta
Kissei Pharmaceutical
In Chapter 6, on the basis of types, the Drugs For Antifolate Compounds market from 2015 to 2025 is primarily split into:
Antineoplastic & immunosuppressant
Antineoplastic
Antimalarial
Antiprotozoal
Broad-spectrum antimicrobial
In Chapter 7, on the basis of applications, the Drugs For Antifolate Compounds market from 2015 to 2025 covers:
Methotrexate
Pemetrexed
Proguanil
Pyrimethamine
Trimethoprim
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Drugs For Antifolate Compounds. Industry analysis & Market Report on Drugs For Antifolate Compounds is a syndicated market report, published as Global Drugs For Antifolate Compounds Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Drugs For Antifolate Compounds market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.